Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease

@article{Selley2003IncreasedCO,
  title={Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease},
  author={M. Selley},
  journal={Neurobiology of Aging},
  year={2003},
  volume={24},
  pages={903-907}
}
  • M. Selley
  • Published 2003
  • Medicine
  • Neurobiology of Aging
Vascular risk factors increase the risk of developing Alzheimer's disease. Increased concentrations of circulating homocysteine are associated with an increased risk of both vascular disease and Alzheimer's disease. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. There is an increase in the concentration of ADMA in the circulation in vascular disease. We measured the concentrations of homocysteine, ADMA and nitric oxide (as nitrate and nitrite) in the… Expand
Asymmetrical Dimethylarginine Is Increased in Plasma and Decreased in Cerebrospinal Fluid of Patients with Alzheimer’s Disease
The Role of Arginine–Nitric Oxide Pathway in Patients with Alzheimer Disease
Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance
  • T. Teerlink
  • Chemistry, Medicine
  • Clinical chemistry and laboratory medicine
  • 2005
Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
...
1
2
3
4
5
...